Neurobehavioral Disorders
Investigators report the findings from a study assessing the impact of insomnia on clinical outcomes in patients with major depressive disorder.
Neurobehavioral Disorders
An additional 53.2 million cases of major depressive disorder and 76.2 million cases of anxiety disorders globally were estimated due to the COVID-19 pandemic.
Neurobehavioral Disorders
AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.
Neurobehavioral Disorders
The percentage of adults with mental health issues increased, as did the percentage reporting that they needed but did not receive help.
Multiple Sclerosis
A team of researchers sought to investigate the bidirectional relationship between multiple sclerosis and major depressive disorder with Mendelian randomization.
Neurobehavioral Disorders
More than half of individuals with prior COVID-19 illness have met the criteria for symptoms of major depressive disorder.
Neurobehavioral Disorders
The goals of this study were to identify functional connectome fingerprints that predict symptom improvement with any treatment and with specific treatment.
Neurobehavioral Disorders
The researchers analyzed data from a large randomized noninferiority trial that compared theta-burst stimulation and high-frequency (10 Hz) rTMS delivered to the left dorsolateral prefrontal cortex.
Migraine and Headache
Dr Amit Akirov examines the evidence suggesting associations between migraine and major depressive disorder (MDD).
Neurobehavioral Disorders
Mindfulness-based cognitive therapy can impact how individuals with recurrent depressive disorder relate to themselves.
